C22H26FN3O5S
Neat
463.52
(3R, 5R)-Rosuvastatin Lactone; 1422954-11-7; N-[4-(4-fluorophenyl)-5-[(E)-2-[(2R, 4R)-4-hydroxy-6-oxooxan-2-yl]ethenyl]-6-propan-2-ylpyrimidin-2-yl]-N-methylmethanesulfonamide; ent-Rosuvastatin Lactone; Rosuvastatin (3R, 5R)-Lactone; N-[4-(4-Fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2R, 4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methyl-methanesulfonamide; Rosuvastatin-5R-lactone;; orb1706296; SCHEMBL12897943; SCHEMBL30571418; AKOS040744142; DA-69088; HY-135406; CS-0112450; Rosuvastatin Impurity 57 ((3R, 5R)-Rosuvastatin Lactone); N-(4-(4-fluorophenyl)-5-((E)-2-((2R and 4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)vinyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide
N-[4-(4-fluorophenyl)-5-[(E)-2-[(2R and 4R)-4-hydroxy-6-oxooxan-2-yl]ethenyl]-6-propan-2-ylpyrimidin-2-yl]-N-methylmethanesulfonamide
InChI=1S/C22H26FN3O5S/c1-13(2)20-18(10-9-17-11-16(27)12-19(28)31-17)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)32(4,29)30/h5-10,13,16-17,27H,11-12H2,1-4H3/b10-9+/t16-,17+/m1/s1